FDA Adverse Event
Death
Summary report: N
RESOLUTE INTEGRITY RX
MDR report key: 2874998
·
Received December 17, 2012
Report
- Report Number
- 9612164-2012-01781
- Event Type
- Death
- Date Received
- December 17, 2012
- Date of Event
- November 18, 2012
- Report Date
- January 17, 2013
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P110013
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
DATE OF DEATH CHANGED FROM 4 DAYS POST IMPLANT OF MEDTRONIC STENTS TO 5 DAYS POST IMPLANT.
Additional Manufacturer Narrative · 1
RESULTS: INHERENT RISK OF PROCEDURE (DEATH, OCCLUSION); DEVICE OR IMAGES NOT RETURNED FOR EVALUATION. CONCLUSIONS: INHERENT RISK OF PROCEDURE (DEATH, OCCLUSION). (B)(4).
Description of Event or Problem · 1
PCI WAS PERFORMED ON PATIENT WITH AMI; PHYSICIAN DEPLOYED ONE NON-MEDTRONIC STENT TO RCA. APPROXIMATELY ONE WEEK LATER PHYSICIAN SUCCESSFULLY DEPLOYED 2 RESOLUTE INTEGRITY DRUG-ELUTING STENTS TO LAD DURING A PLANNED PCI. APPROXIMATELY 4 DAYS LATER PATIENT SUFFERED CARDIOPULMONARY ARREST, CAG SHOWED OCCLUSION IN LAD. ASPIRATION WAS PERFORMED ON THE PATIENT, BUT THEY EXPIRED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | RESOLUTE INTEGRITY RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND | 0006203170 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00049 YR | Death | CLOPIDOGREL AND ASPIRIN. |